Tech Company Financing Transactions

SurgRx Funding Round

SurgRx closed a $21 million Series E funding round on 7/25/2005. Investors included New Enterprise Associates.

Transaction Overview

Company Name
Announced On
7/25/2005
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series E
Investors

New Enterprise Associates (Lead Investor) (Sigrid VanBladel)

Proceeds Purpose
Funds will be used to aid the company in marketing EnSeal products internationally

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
101 Saginaw Drive
Redwood City, CA 94063
USA
Email Address
Overview
SurgRx, a medical device manufacturer based in Palo Alto, California. SurgRx is the developer of the EnSeal System, a proprietary, FDA-approved technology that empowers surgeons to cut and seal blood vessels and tissue quickly, efficiently, and with virtually no unwanted effects.
Profile
SurgRx LinkedIn Company Profile
Social Media
SurgRx Company Twitter Account
Company News
SurgRx News
Facebook
SurgRx on Facebook
YouTube
SurgRx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Csaba Truckai
  Csaba Truckai LinkedIn Profile  Csaba Truckai Twitter Account  Csaba Truckai News  Csaba Truckai on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/25/2005: Primarion venture capital transaction
Next: 7/25/2005: TherOx venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary